<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">8897442</PMID>
        <DateCompleted>
            <Year>1997</Year>
            <Month>03</Month>
            <Day>24</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>30</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0028-1298</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>354</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>1996</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Naunyn-Schmiedeberg's archives of pharmacology</Title>
                <ISOAbbreviation>Naunyn Schmiedebergs Arch. Pharmacol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Expression of five somatostatin receptor mRNAs in the human brain and pituitary.</ArticleTitle>
            <Pagination>
                <MedlinePgn>411-9</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>The messenger RNA (mRNA) expression of somatostatin receptors sst1-5 was studied in human brain by in situ hybridization histochemistry using specific oligonucleotide probes. sst1 receptor mRNA was mainly found in the outer and intermediate layers of cerebral cortex, hippocampal formation (CA1, dentate gyrus, entorhinal cortex), hypothalamus, substantia nigra, medullary nuclei and dentate nucleus. sst2 transcripts were present in the deep layers of the cerebral cortex, amygdala, hippocampal formation (CA1, dentate gyrus, subiculum, entorhinal cortex), the granular layer of the cerebellum and pituitary. sst3 receptor mRNA was localized in the cerebral cortex, hippocampal formation (CA1, dentate gyrus), several medullary nuclei and the granule and possibly Purkinje cell layer of the cerebellum and at very low levels in the pituitary. sst4 receptor mRNA was absent in the cerebral cortex. Intermediate signals were observed in the dentate gyrus of the hippocampus and several medullary nuclei while an intense expression was found in the granule and Purkinje cell layer of cerebellum. sst5 transcripts were present in the pituitary and the granule layer of the cerebellum. The present results show that mRNAs of sst1-4 somatostatin receptors have distinct distribution patterns within the human brain, although there is overlap in several regions. sst5 receptor mRNA expression appears to be very low and restricted to the cerebellum and pituitary. The distribution pattern observed in the human brain was broadly similar to that reported previously in the rat brain. The high expression levels of at least two somatostatin receptor subtype mRNAs (sst2 and sst5) in the pituitary gland suggest that somatostatin may affect neuroendocrine functions via more than one receptor.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Thoss</LastName>
                    <ForeName>V S</ForeName>
                    <Initials>VS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Preclinical Research, SANDOZ Pharma Ltd., Basel, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>PÃ©rez</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Probst</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hoyer</LastName>
                    <ForeName>D</ForeName>
                    <Initials>D</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>Naunyn Schmiedebergs Arch Pharmacol</MedlineTA>
            <NlmUniqueID>0326264</NlmUniqueID>
            <ISSNLinking>0028-1298</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015345">Oligonucleotide Probes</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D017481">Receptors, Somatostatin</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C098681">somatostatin receptor subtype-4</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C101130">somatostatin receptor type 1</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>8X85ZJG6XJ</RegistryNumber>
                <NameOfSubstance UI="C094573">somatostatin receptor 5</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>D73QL0OMU2</RegistryNumber>
                <NameOfSubstance UI="C093733">somatostatin receptor 2</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006651" MajorTopicYN="N">Histocytochemistry</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017403" MajorTopicYN="N">In Situ Hybridization</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015345" MajorTopicYN="N">Oligonucleotide Probes</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010902" MajorTopicYN="N">Pituitary Gland</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017481" MajorTopicYN="N">Receptors, Somatostatin</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>1996</Year>
                <Month>10</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>1996</Year>
                <Month>10</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>1996</Year>
                <Month>10</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">8897442</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Neuroscience. 1995 Apr;65(4):1087-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7617164</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Pharmacol. 1985 Jul 11;113(1):129-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2864261</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Res. 1986 Nov 19;398(1):141-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3026563</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 1985 Jul 19;229(4710):289-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2861661</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Pharmacol Sci. 1995 Mar;16(3):86-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7792934</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1992 May 15;89(10):4618-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1374909</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Res. 1981 Aug 10;218(1-2):219-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6168327</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 1983 Sep 2;221(4614):972-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6136092</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Res. 1992 Feb 28;573(2):251-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1354548</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Naunyn Schmiedebergs Arch Pharmacol. 1996 May;353(6):648-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8738298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 1993 Sep 15;195(2):844-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8373420</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurochem. 1993 Oct;61(4):1549-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8377006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Comp Neurol. 1985 Jun 22;236(4):423-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2865277</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Pharmacol. 1996 Apr;117(8):1673-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8732275</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuropharmacology. 1995 Dec;34(12):1673-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8788965</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Res Mol Brain Res. 1995 Dec 28;34(2):321-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8750836</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurosci Lett. 1985 May 23;56(3):377-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2862613</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Endocrinol. 1992 Dec;6(12):2136-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1337145</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Naunyn Schmiedebergs Arch Pharmacol. 1994 Nov;350(5):441-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7870182</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Neurosci. 1994 Dec 1;6(12):1883-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7704298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Life Sci. 1985 May 13;36(19):1829-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2859510</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuropharmacology. 1996 Jun;35(6):713-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8887980</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Pharmacol. 1995 Mar 15;289(1):151-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7781706</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Neurosci. 1993 Jan;16(1):34-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7679236</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Res. 1992 Feb 28;573(2):299-304</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1354549</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroscience. 1991;41(2-3):581-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1678504</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11151-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1360663</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurochem. 1986 Feb;46(2):359-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2867123</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 1992 Oct 5;267(28):20422-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1328199</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):251-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1346068</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Pharmacol. 1995 Mar 15;289(1):163-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7781707</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Pharmacol. 1996 Feb 15;297(1-2):145-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8851178</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Res. 1990 Jul 9;522(2):342-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1977497</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroscience. 1994 Mar;59(1):175-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8190266</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroscience. 1995 Jan;64(1):241-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7708209</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Endocrinology. 1993 Dec;133(6):2561-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8243278</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Life Sci. 1995;56(5):333-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7530798</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Naunyn Schmiedebergs Arch Pharmacol. 1994 Feb;349(2):145-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8170498</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Res. 1987 Mar 17;406(1-2):391-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2882820</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Naunyn Schmiedebergs Arch Pharmacol. 1995 Dec;352(6):607-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9053731</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroscience. 1986 Jun;18(2):329-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2874525</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Pharmacol. 1992 Dec;42(6):939-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1362243</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>